CSF tau protein: A new prognostic marker for Guillain-Barré syndrome

Authors:
  • YSY. Shiga
    Y. Shiga
  • SSS. Sato
    S. Sato
  • AOA. Ohnuma
    A. Ohnuma
  • HNH. Nomura
    H. Nomura
  • HAH. Arai
    H. Arai
  • SKS. Kusunoki
    S. Kusunoki
  • MIM. Ikeda
    M. Ikeda
  • YIY. Itoyama
    Y. Itoyama

Abstract
We measured the CSF tau protein levels in 26 patients with Guillain-Barré syndrome. The levels of the poor outcome group (Hughes grade at 6 months was between II and VI, n = 6) were higher than those of the good outcome group (0 or I, n = 20) (p < 0.0005). The higher levels of CSF tau may reflect axonal degeneration and could predict a poor clinical outcome in Guillain-Barré syndrome.

This publication has 10 references indexed in Scilit: